CardioNerds Dan Ambinder and Dr. Devesh Rai join cardiology fellows and National Lipid Association lipid scholars Dr. Oby Ibe from Temple University and Dr. Elizabeth Epstein from Scripps Clinic. They discuss a case involving a patient with elevated Lp(a). Dr. Jessica Pena provides expert commentary. Drs. Oby Ibe and Elizabeth Epstein drafted notes. CardioNe ... Show More
Apr 2025
#174 Lp(a) and ASCVD Risk: 5 Pearls Segment
What does Lipoprotein(a) tell us that a standard lipid panel doesn’t? Should we be testing everyone for it? Dive into the genetics, clinical implications, and evolving management strategies for Lp(a). Learn how to interpret results, counsel patients, and navigate topics with limi ... Show More
43m 20s
Apr 2025
Lipoprotein(a) and Cardiovascular Disease | Geriatric Pharmacy Focus
<p>In this episode of Geriatric Pharmacy Focus, we welcome back Dr. Thomas Dayspring for an in-depth discussion on lipoprotein(a). We explore what it is, how to test for it, available treatment options, and the pharmacist's role in raising awareness for this genetic cardiovascula ... Show More
49m 19s
Dec 2021
Dec 3, 2021 This Week in Cardiology Podcast
The AMAZE trial of left atrial appendage isolation, non-statin oral lipid lowering drugs, EHR alerts, non-MD care, and obesity are the topics John Mandrola, MD, discusses in this week's podcast. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I – ... Show More
20m 16s
<p>Lipid Drugs: Part 1</p>
<p> </p>
<p>Guest: Alicia A. Mickow, APRN, C.N.P., M.S.N</p>
<p>Host: Stephen L. Kopecky, M.D.</p>
<p> </p>
<p>In Part 1 of this two-part series, listeners will learn the challenges of managing patients who are statin-intolerant, the range of available ... Show More
